Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) — Stock Score Summary

Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) has a MoatMap StockRank of 10/100 based on Quality (52/100), Value (12/100), and Momentum (27/100) factor scores. The current signal is STRONG SELL. Shenzhen Chipscreen Biosciences is a clinical-stage biopharmaceutical company. It lacks the established commercial cash flows, high ROIC, and validated manufacturing scale of a high-conviction CDMO or global pharma compounder.

Shenzhen Chipscreen Biosciences Co., Ltd. is a pioneer in the discovery and development of original small-molecule innovative drugs, focusing on oncology, metabolic diseases, and autoimmune disorders. Its flagship product, Chidamide (Epidaza), was China's first home-grown epigenetic cancer drug, establishing the company's strong clinical and commercial moat. The firm is recognized as a leading research-driven specialty pharmaceutical player with a robust pipeline of first-in-class and best-in-class candidates.

Key Financial Metrics

Price$3.66
Market Cap$1.8B
P/E (TTM)106.33
P/E (Forward)-127.60
Price/Book4.20
Return on Equity4.7%
Return on Invested Capital3.1%
Debt/Equity59.73
Gross Margin87.0%
Operating Margin16.4%
Revenue Growth58.4%
Dividend Yield0.2%
Free Cash Flow$1M

Shenzhen Chipscreen Biosciences Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shenzhen Chipscreen Biosciences Co., Ltd.’s (688321.SS) StockRank?
MoatMap’s StockRank for Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) is 10/100, with a Strong Sell signal. It is a composite of Quality (52), Value (12), and Momentum (27) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shenzhen Chipscreen Biosciences Co., Ltd. have an economic moat?
Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shenzhen Chipscreen Biosciences Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) is Strong Sell, based on a StockRank of 10/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shenzhen Chipscreen Biosciences Co., Ltd. in?
Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks688321.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock